Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2003

View Archived Issues

Inex regains 100% ownership of Onco TCS

AD-452 enters phase I testing

CytoGenix begins preclinical trials with antiherpesvirus DNA drug

New enzyme-based cardiovascular risk assessment test launched by the Mayo Clinic

Indan-based anorectic agents developed at Aventis

New antiproliferative pteridinones synthesized by Boehringer Ingelheim researchers

U. of Connecticut researchers describe CB1 modulators for obesity and other uses

Novel 5alpha-reductase inhibitors covered by Jenapharm patent

Antipsychotic optically active iloperidone metabolites patented by Novartis

New series of PDE5 inhibitors in early development at Schering-Plough

Novartis designs series of cathepsin K inhibitors

Entomed and Achillion collaborate on antiviral drug discovery

Insmed begins named-patient program for SomatoKine

Pegasys more effective than interferon in difficult-to-treat hepatitis B

Zadaxin combination therapy demonstrates sustained response in hepatitis B patients

Preliminary phase II results for RDP-58 in ulcerative colitis and Crohn's disease

Long-term treatment with Fosrenol controls phosphate in end-stage renal disease

Insmed's rhIGFBP-3 improves effect of cancer therapies, inhibits tumor growth

AVI BioPharma's NeuGene program advances

Discovery's lung surfactant shows significant antiinflammatory properties

Enema formulation of alicaforsen assessed in new phase II ulcerative colitis trial

FTI-277 inhibits growth and induces apoptosis in drug-resistant multiple myeloma cells

Anticoagulant efficacy of JVT-803 demonstrated in porcine model of hemodialysis

Evidence for potential of SB-277011-A in drug dependence and psychosis

Inflazyme to acquire GlycoDesign

Microbially produced angiogenesis inhibitor discovered by RIKEN

SAR in a series of acyl sulfonamide antiproliferative compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...